โข
RX
RXST
RxSight, Inc. Common Stock
yahooOPHTHALMIC GOODS
--
Price Chart
Market Cap
409.11M
Volume
1.81M
52W High
$34.71
52W Low
$6.32
Open
$0.00
Prev Close
$9.66
Day Range
0.00 - 0.00
About RxSight, Inc. Common Stock
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
Latest News
RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer
GlobeNewswire Inc.โขJan 11
RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - RXST
BenzingaโขSep 22
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
GlobeNewswire Inc.โขSep 21
ืืืจ ืืืืขื ืืืืจืื ืืชืืืขื ื ืื RXST: ืจืืื, ืืืขืฅ ืืืฉืงืืขืื ืืืืื, ืืขืืื ืืฉืงืืขืื ื- .RxSight, Inc ืขื ืืคืกืืื ืฉื ืืืชืจ ื-100 ืืืฃ ืืืืจ ืืืืืื ืืืขืืฅ ืืคื ื ืืืืขื ืืืืจืื ืืืฉืื ืฉื 22 ืืกืคืืืืจ ืืชืืืขื ืืืฆืืืืช ืื ืืืจืืช ืขืจื - RXST
GlobeNewswire Inc.โขSep 21
RXST DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages RxSight, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 22 Deadline in Securities Class Action โ RXST
GlobeNewswire Inc.โขSep 21
ืืืจ ืืืืขื ืืืืจืื ืืชืืืขื ื ืื REPL: ืจืืื, ืืืขืฅ ืืืฉืงืืขืื ืืืืื, ืืขืืื ืืช ืืฉืงืืขื Replimuneย Group, Inc. ืฉืฆืืจื ืืคืกืืื ืฉื ืืืชืจ ื- 100 ืืืฃ ืืืืจ ืืืืืื ืืืขืืฅ ืืคื ื ืืืืขื ืืืืจืื ืืืฉืื ืืชืืืขื ืืืฆืืืืช ืื ืืืจืืช ืขืจื ืฉืืืืฉื ืจืืฉืื ื ืขื ืืื ืืืฉืจื โ REPL
GlobeNewswire Inc.โขSep 21
INVESTOR CLASS ACTION: RxSight, Inc. Investors are Reminded of the Ongoing Securities Fraud Lawsuit after Stock Plummeted 38% -- Contact BFA Law
GlobeNewswire Inc.โขSep 20
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit with the Schall Law Firm
BenzingaโขSep 18